Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 2Melanoma 1Lung Neoplasms 1Glioma 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Radiosurgery 9Magnetic Resonance Spectroscopy 6pembrolizumab 4Radiotherapy 4Nivolumab 4Fluorodeoxyglucose F18 4cabozantinib 3Specimen Handling 3Paclitaxel 3Melphalan 3Ipilimumab 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Busulfan 3lenvatinib 2entrectinib 2cediranib 2Thiotepa 2Sunitinib 2Radiation 2Peripheral Blood Stem Cell Transplantation 2Injections 2Ifosfamide 2FAPI-46 2Etoposide 2Carboplatin 2Bone Marrow Transplantation 2Bevacizumab 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × clevudine × Genitourinary × Clear all
NCT04752267 2024-05-24

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

University of Southern California

Phase EARLY_PHASE1 Completed
10 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioma, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡